Market Research Blog – Page 1859 – New Product Development

Thoracolumbar Stabilization Devices Market is expected to grow steadily at a 5.5% annual rate and reach US$2.1 Billion by 2033 | FMI Analysis

The Thoracolumbar Stabilization Devices Market is on track for significant growth, fueled by rising demand and advancements in medical technology. A recent analysis by Future Market Insights (FMI) forecasts a robust Compound Annual Growth Rate (CAGR) of 5.5% over the next decade. This translates to a projected market valuation of US$2.066.2 million by 2033, reflecting a substantial increase from US$1.206.7 million in 2023.

The increasing demand for thoracolumbar stabilization devices, which emphasizes their rising relevance in managing spinal instability, marks a paradigm change in the field of spinal healthcare. With significant momentum, these devices are becoming a serious contender to replace conventional spinal fusion techniques.

In contrast to fusion methods that eliminate all movement, thoracolumbar stabilization devices preserve a degree of spine mobility, striking a delicate balance between stability and flexibility. Beyond contributing to straightening the spine’s curve, these devices provide substantial support to the thoracic spine. This transformative advancement in spinal healthcare represents a significant milestone for the industry, aligning with the evolving needs and preferences of patients seeking effective and flexible solutions.

Request a Sample of this Report By Using Work Email to Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4001

Thoracolumbar Stabilization Devices Market: Drivers and Restraints

The rising occurrence of spine injuries and fractures is likely to increase the market for Thoracolumbar Stabilisation Devices. The growing demand for non-invasive surgical techniques is also projected to propel the Thoracolumbar Stabilisation Devices market forward. The rising prevalence of spine abnormalities among the elderly is also likely to drive the market for Thoracolumbar Stabilisation Devices.

The high initial cost of these devices may limit the market expansion of Thoracolumbar Stabilisation Devices.

Thoracolumbar Stabilization Devices Market: Overview

The market for Thoracolumbar Stabilisation Devices is predicted to expand significantly throughout the forecast period. Spinal injury and chronic back pain are among the most common disorders, and their increasing prevalence is likely to fuel the growth of the Global Thoracolumbar Stabilization Devices Industry.

Titanium gadgets are predicted to be the greatest revenue-generating market due to their lightweight and active character. Because all surgical stabilization of the thoracolumbar region begins with the posterior implant, posterior Thoracolumbar Stabilisation Devices are expected to generate more revenue than anterior devices.

The market for Thoracolumbar Stabilisation Devices is predicted to increase steadily due to cost-effectiveness and better disease management when compared to analgesics. These devices are available in several shapes and sizes, allowing users to select from a wide range of alternatives, which is likely to boost the revenue of the Thoracolumbar Stabilisation Devices market.

Thoracolumbar Stabilization Devices Market: Region-Wise Outlook

Geographically, the Global Thoracolumbar Stabilization Devices Industry can be segmented into the regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa. North America is the biggest and most attractive market for thoracolumbar stabilization devices due to the presence of major players, awareness among people, better healthcare infrastructure, and reimbursement policies.

Followed by which is Europe. Asia Pacific region is expected to be fastest fastest-growing Global Thoracolumbar Stabilization Devices Industry due to the large patient pool, increasing healthcare infrastructure, and awareness among people.

Thoracolumbar Stabilization Devices Market: Key Players

Some of the market participants in the Global Thoracolumbar Stabilization Devices Industry are, B. Braun Melsungen AG, Zimmer, Inc., Coligne AG, Yellowsteps SAS, Medyssey Co. Ltd., DePuy Synthes Company, Aesculap Implant Systems, LLC, Ulrich Medical, Medtronic Public Limited Company, and Stryker. Companies are focusing on the advancement of devices and the development of minimally invasive screws and roads.

The research report presents a comprehensive market assessment and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and grades.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/4001

Key Segments Profiled in the Thoracolumbar Stabilization Devices Market Survey

By Device Type:

Anterior Stabilization Device
Posterior Stabilization Device
Retractors

By Material:

Titanium
Stainless Steel

By End Use:

Hospitals
Clinics
Ambulatory Surgical Centers

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Robotic Biopsy Devices Market is expected to grow at a 9.3% CAGR and reach US$1.1 Billion by 2033 | FMI Analysis

The Robotic Biopsy Devices Market is on the cusp of a remarkable transformation, fueled by continuous advancements and a growing demand for precise medical diagnoses. A recent analysis reveals the market reached a value of US$440.2 million in 2023, and this upward trend is expected to accelerate. Experts predict a robust Compound Annual Growth Rate (CAGR) of 9.3% over the next decade, propelling the market to a staggering US$1.1 billion by 2033. This signifies a significant rise in the adoption of these innovative medical tools that are revolutionizing the field of diagnostics.

The market for Robotic Biopsy Devices is anticipated to grow at a fast pace over the projected years due to the rising need for safe and effective minimally invasive procedures and the growing use of automated systems in the healthcare sector. It can be further attributed to the rapid transformation of conventional healthcare systems to integrated digital technology.

Request a Sample of this Report By Using Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15412

Key Takeaways: Robotic Biopsy Devices Market

By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
By application, the brain biopsy category is leading the Global Robotic Biopsy Devices Market and is projected to exhibit a CAGR of 3% during the forecast period.
By end user, hospitals held around 5% of the Global Robotic Biopsy Devices Industry share in 2021.
The U.S. currently dominates the North America Robotic Biopsy Devices market and it generated a share of about 8% in 2021.
The U.K. is set to hold a share of nearly 2% in the Global Robotic Biopsy Devices Market during the assessment period.

“Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of Robotic Biopsy Devices,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Competition Landscape: Global Robotic Biopsy Devices Industry

The market for Robotic Biopsy Devices is oligopolistic, with the presence of a few established manufacturers. The product range of every player in the market varies as per the competitors’ licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.

In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.

Robotic Biopsy Devices Market Key Players

Medtronic
Renishaw plc
iSYS Medizintechnik GmbH
Mazor Robotics
Biobot Surgical Pte Ltd
Medrobotics
Medtech SA

What Does the Robotic Biopsy Devices Market Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Global Robotic Biopsy Devices Industry in its latest study, presenting a historical demand assessment of 2012 to 2021 and projections for 2022 to 2032.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/15412

Robotic Biopsy Devices Market Outlook by Category

By Product:

Systems
Instrument & Accessories

By Application:

Brain Biopsy
Lung Biopsy
Prostate biopsy
Others

By End User:

Hospitals
Ambulatory Surgical Centers
Academic & Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Veterinary Orthotics-Prosthetics Market Expected to Reach US$164.2 Million by 2033, with a CAGR of 9.5% | FMI

The Veterinary Orthotics-Prosthetics Market is experiencing explosive growth, driven by a rising focus on pet health and well-being. According to a recent report by Future Market Insights (FMI), a leading market research firm, the market size surpassed an impressive US$66.5 million in 2023. This positive trend is expected to continue, with projections indicating the market will reach a remarkable US$164.2 million by 2033. This translates to a robust Compound Annual Growth Rate (CAGR) of 9.5% over the next decade.

The research from FMI states that the increasing number of instances involving damaged animals is the main cause of this demand spike. For animals with physical difficulties, veterinary orthotic prosthetic devices offer vital support, alignment, immobilization, muscle strengthening, and improved functioning. They are now essential to the care and recuperation of animals as a result, especially in the wake of injuries or illnesses that affect their mobility and overall well-being.

The market study depicts an extensive analysis of all the players running in the Global Veterinary Orthotics-Prosthetics Industry report based on distribution channels, local networks, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Global Veterinary Orthotics-Prosthetics Industry report.

In its latest business report, Future Market Insights elaborates on the current situation of the Global Veterinary Orthotics-Prosthetics Industry in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players based on demand patterns, and future prospects.

Request a Sample of this Report By Using Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4512

Canine Rehabilitation’s Role in Shaping the Veterinary Orthotics-Prosthetics Market”

The Global Veterinary Orthotics-Prosthetics Industry is on an upward trajectory, largely fueled by the increasing awareness of rehabilitation options for animals. Canine rehabilitation, in particular, has witnessed significant advancements in contemporary veterinary medicine, driven by ongoing research initiatives from various institutions, thereby amplifying the demand for veterinary orthotics and prosthetics.

The market is further poised for growth, spurred by continuous innovations in prosthetic device technology, the trend towards customized prosthetic solutions, and the global consolidation of the Global Veterinary Orthotics-Prosthetics Industry.

Key Challenges for the Global Veterinary Orthotics-Prosthetics Industry:

Limited Government and Non-Profit Support: A notable impediment to the Global Veterinary Orthotics-Prosthetics Industry’s growth is the lack of substantial support from government and non-profit organizations.

Awareness Gap: The market is hindered by a deficiency in awareness regarding the availability and benefits of veterinary orthotics-prosthetics.

Professional Expertise Shortage: Inappropriate use of these devices is another constraint, stemming from the scarcity of skilled professionals, which may restrict the sales of veterinary orthotics and prosthetics.

What key insights does the Veterinary Orthotics-Prosthetics Market research provide?

Historical and current year revenue of related Veterinary Orthotics-Prosthetics market players analyzed at the regional level.
One by one company profile of prominent stakeholders.
Analysis of the Veterinary Orthotics-Prosthetics market size based on product type and end-use type.
Accurate Veterinary Orthotics-Prosthetics market forecast in terms of value and volume in numbers and percentages.
Demand prospect of each segment covered in the report.

Key Companies Profiled:

OrthoPets LLC.
Animal Ortho Care
AAA Orthotics and Prosthetics
Anchor Orthotics & Prosthetics
Animal Care Castle Rock OrthoPets Castle Rock
Appletree Orthotic Services Ltd
Animal Orthocare
Avondale Veterinary Healthcare Complex OrthoPets Iowa
Buddy Braces
Dogs in Motion Canine Rehabilitation OrthoPets Australia
Equisport Medicine OrthoPets Washington
com
Hanger Clinic
Holistic vet OrthoPets South Africa
G. McGinness Prosthetics & Orthotics
K-9 Orthotics & Prosthetics

Veterinary Orthotics-Prosthetics Market Key Segments

By Product Type:

Braces
Stifle braces
Carpal/Tarsal braces
Hip braces
Contracture Bracing
Deformity Braces
Prosthetics
Others

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-4512

By End User:

Veterinary Hospitals
Prosthetics clinics
Rehabilitation Center
Others

By Region:

North America
Europe
Asia-Pacific
Latin America
MEA

The Veterinary Orthotics-Prosthetics Market research gets rid of the following queries:

How the market for Veterinary Orthotics-Prostheticss is expected to shape in the coming ten years?
What strategies are the Veterinary Orthotics-Prosthetics market vendors implementing to stay ahead of their rivals?
Why are consumers shifting towards alternative Veterinary Orthotics-Prosthetics products?
What innovative technologies are the Veterinary Orthotics-Prosthetics players using to get an edge over their rivals?
What are the restraints affecting the growth of the Global Veterinary Orthotics-Prosthetics Industry?

Why choose Future Market Insights?

Modern technologies, such as artificial intelligence, to provide updated industry trends.
Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective.
Interaction with research scientists and development heads to understand the nature of the market more precisely.
Three-step quality check process – Data collection, triangulation, and validation.
24/7 availability of services.

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Stabilometric Platform Market is expected to grow at a 7.3% compound annual growth rate and reach US$2.42 Billion by 2033 | FMI analysis

The Stabilometric Platform Market is finding its footing, with a projected surge driven by the increasing need for advanced balance and movement assessment tools. According to a recent study by leading industry specialists, the market is gearing up for a stellar Compound Annual Growth Rate (CAGR) of 7.3% from 2023 to 2033. This translates to significant market expansion, with the value expected to climb from US$1.19 billion in 2023 to a staggering US$2.42 billion by 2033.

These distinguished experts’ thorough market research, projections, and trends provided insight into the dynamic factors pushing the global stabilometric platform industry into unprecedented territory. Several variables, such as the confluence of expanding healthcare awareness, technology improvements, and an increased need for accurate diagnostic instruments, are responsible for the market value growth.

At the heart of this industry’s growth is the Stabilometric Platform, a groundbreaking device designed to measure body movements with utmost precision. Operating in a standing position, the stadiometer – a force-measuring platform – is pivotal to understanding and monitoring the body’s balance. The platform, with its flat and regular surface, is intricately connected to four force transduction systems. Achieving and maintaining the correct balance in the human body necessitates a delicate collaboration of the nerve, musculoskeletal system, and balance organs, all monitored incessantly by the central nervous system.

Request a Sample of this Report By Using Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5047

High blood pressure has an impact on all aspects of the balance system. The central nervous system regulates the body’s vertical position by slightly shifting the centre of gravity. Using appropriate movement strategies, the correct position of the centre of gravity is obtained. The presence of hypertension impairs the functioning of the control system, resulting in the appearance of the first symptoms of losing control over the body’s balance. A test on a stabilometric platform can be used to detect this symptom.

A force measuring platform is a device similar to a weighing scale that quantifies the centre of pressure using a set of force transducers. The analysis of the centre of pressure is part of the stabilometric platform evaluation. This centre of pressure reflects the motor pattern at the ankle, and the central nervous system responds to correct the body’s centre of mass imbalance. Stabilometric platforms collect information about a person’s postural control and balance. Data obtained from the stabilometric platform has resulted in a few medical advances. However, because the data obtained cannot be analysed directly, some data analysis techniques must be used. Balance control is a sophisticated neuronal mechanism based on both unconditional and conditioned reflexes. Because the mechanism requires the participation of brain regions, posture support mechanism training can be a highly effective tool for rehabilitation.

The stabilometric platform is widely used for training balance skills with visual biofeedback. The stabilometric platform automatically evaluates parameters such as the length of the ideal trajectory, trial type, target point location, speed and length of the real trajectory of the projections of the centre of gravity between the target points. The designations used to indicate the direction of body movements during stabilometric platform measurements are Left (L), Right (R), Anterior (A), and Posterior (P) (P). These guidelines are always defined from the subject’s perspective. The use of a stabilometric platform is a reproducible and objective method for assessing and documenting balance skills. The stabilometric platform allows for the localization of the person’s centre of gravity on the ground projection, the dynamics and localization of the centre of gravity of each foot, load distribution between the left and right foot, and so on. This data can be used to evaluate vestibular, postural, dental, and podiatric dysfunctions, as well as orthopaedic and pathologies.

Initially, the stabilometric platform was only used to assess patient balance and postural control. However, it is now recognised as a valuable tool for treating and diagnosing balance disorders.

Stabilometric Platform Market: Drivers and Restraints

The Global Stabilometric Platform Industry is expanding as people become more aware of the various diagnosis options for balance and postural control disorders. The market for stylometric platforms is being driven by factors such as improved quality of life, functional independence, and increased awareness of balance skills, among others. However, the high cost of equipment and the scarcity of skilled personnel to operate these platforms are likely to stymie market growth.

Stabilometric Platform Market: Overview

Stabilometric platforms are the most accurate equipment in testing balance disorders. Based on the types, the Global Stabilometric Platform Industry is segmented into single-function and multi-function. Multi-function stabilometric platform is the most widely used stabilometric platform type across the globe.

Stabilometric Platform Market: Regional Overview

North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa are the regions where the Global Stabilometric Platform Industry is divided. North America is expected to dominate the market during the forecast period due to the high acceptance of innovative devices and an increase in the geriatric population. The Western European market for stabilometric platforms is expected to be the second largest. The Asia Pacific market is expected to grow steadily due to the current low awareness of balance and postural control techniques, as well as low healthcare expenditure.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5047

Stabilometric Platform Market: Key Players

Some of the players identified in the Global Stabilometric Platform Industry include MEDI-CARE SOLUTIONS srl, Sensing Future Technologies, TECHNO CONCEPT, Vertigomed, WOODWAY, Easytech srl, Biodex, Man&Tel, Framiral, Vestibular Research & Development, LLC. (Balanceback), Techmed, etc.

Stabilometric Platform Market Key Segments

By Types:

Single function
Multi-function

By End User:

Hospitals
Rehabilitation Centers
Nursing Homes

By Regions:

North America
Europe
Asia Pacific
Latin America
MEA

Why Future Market Insights?

Comprehensive analysis of evolving purchase patterns across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Portable Anesthesia Systems Market would grow at a 6.6% annual rate and reach US$933.4 Million by 2033 | FMI

The Portable Anesthesia Systems Market is poised for significant growth, fueled by the increasing need for adaptable and efficient anesthesia solutions across diverse healthcare settings. A recent forecast by Future Market Insights (FMI) predicts a robust Compound Annual Growth Rate (CAGR) of 6.6% from 2023 to 2033. This translates to a substantial market expansion, reaching a projected valuation of a staggering US$933.4 million by 2033, compared to US$493.6 million in 2023.

The market for portable anesthesia systems has grown as a result of advances in medical technology that have produced small, incredibly efficient devices. These state-of-the-art devices change patient care by enabling medical personnel to provide anesthesia in a portable and useful way.

Request a Sample of this Report By Using Your work email to get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5182

Portable anesthesia systems are essential due to an upsurge in surgical operations worldwide. With the flexibility and mobility that these systems provide, medical personnel may provide anesthesia in a variety of situations outside of conventional operating rooms, including ambulatory surgical facilities, dentist offices, and distant sites. The capacity to provide anesthesia in these circumstances broadens the scope of medical care and makes therapy for patients more practical and accessible.

The development of the Global Portable Anesthesia Systems Industry has been greatly aided by the miniaturization trend of medical equipment. Healthcare professionals may provide anesthesia in a variety of clinical settings, including distant or resource-constrained locations, owing to the compact, lightweight, and portable design of these devices. The mobility aspect makes it possible for medical personnel to respond to emergencies or give anesthesia during medical missions or disaster relief activities.

The market for portable anesthetic systems is projected to develop as a result of ongoing technological advancements. For instance, integrating real-time data exchange, wireless connectivity, and enhanced monitoring capabilities can increase patient safety and better anesthetic management. The development of more user-friendly and intuitive interfaces due to technological developments may make portable anesthetic devices more available to healthcare providers.

Asia Pacific is predicted to dominate the global market during the forecast period. In recent years, surgical operations in Asia Pacific have significantly increased. The demand for procedures requiring the administration of anesthesia has increased as a result of the growing frequency of chronic illnesses, lifestyle-related ailments, and age-related problems. Patients from all over the world travel to India, Thailand, and Malaysia, which have also become well-known medical tourism destinations. These factors proliferate market growth in Asia Pacific.

Portable Anesthesia Systems Market Recent Developments Observed by FMI:

By absorbing Penlon Ltd.’s shares from BPL Medical Technology in January 2022, Medcaptain Medical Technology Ltd. (MMTL) acquired Penlon Ltd.
Arab Health 2022 included a live demonstration of Medovate’s state-of-the-art regional anesthetic device SAFIRA in January 2022. Medovate, a producer of medical equipment, collaborated with doctors from the National Health Service (NHS) of the United Kingdom to develop SAFIRA, which is expected to transform regional anesthesia globally.
The next-generation computer-assisted local anesthetic from Ronvig Dental was introduced in May 2021 and is called CALAJECTTM. It was selected ‘2022 Top Award Winner – Anesthetic Device’ by Dental Advisor. The mechanism regulates the flow rate to provide a steady and gentle delivery of anesthetic. Even palatal injections may be administered to patients with minimal discomfort.

Prominent Players in the Portable Anesthesia Systems Market

WandDental
Milestone Scientific
Evident Inc.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/5182

Portable Anesthesia Systems Market Segmentation

By Application:

Medical Specialties
Anesthesiology
Orthopedic Surgery
Pain Medicine
Physical Medicine/Rehabilitation
Primary Care/Urgent Care
Rheumatology
Sports Medicine
Dental Specialties
Others

By Surgery Type:

Open Surgery
Minimally Invasive Surgeries

By End Users:

Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East & Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Veterinary Glucometer Market is expected to grow by 5% and reach US$574.9 Million by 2033 | FMI Report

The rising tide of diabetes in pets is driving a surge in the Veterinary Glucometer Market, poised to reach a remarkable US$574.9 million by 2033. This translates to a significant leap from its current value of US$351.3 million in 2023, according to a recent analysis by Future Market Insights Inc. This impressive growth trajectory, fueled by a Compound Annual Growth Rate (CAGR) of 5.0%, signifies a potential revolution in animal healthcare, empowering pet owners to better manage their furry companions’ diabetes.

The global veterinary glucose meter market is adapting to the growing demand for cutting-edge diagnostic tools in veterinary care by introducing cutting-edge technologies that measure animal blood glucose levels with previously unheard-of precision. Veterinary professionals are now equipped with cutting-edge tools to diagnose and treat illnesses like diabetes, ultimately improving animal health outcomes.

Emerging trends in the Global Veterinary Glucometer Industry indicate a significant rise in cases of animal diabetes. The efficiency of glucometers, specially tailored for dogs and cats, is expected to drive the demand for veterinary glucometers through 2032. Key players in the industry are responding to this demand by introducing new portable devices and setting new standards and manufacturing trends for the market.

The expanding veterinary glucometer market size is attributed to its easy-to-use glucose test in practice in the field or at home. It is based on biosensors and auto-code technology. These veterinary glucometers have an additional bell or whistle and can upload readings in an electronic format after performing the test. These are some of the primary factors boosting the demand for veterinary glucometers.

Request a Sample of this Report By Using Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5367

What are the Major Drivers and Restraints of the Veterinary Glucometer Market?

The global market of veterinary glucometers is expected to be driven by advancements in technology. The market is expected to grow by some factors such as clients expecting a higher level of care and nominally invasive procedures for their pets which propositionally boost the sales of veterinary glucometers.

Based on animal type, it is the major segment of the veterinary glucometer market which includes companion animals such as dogs and cats. The other segment of the Global Veterinary Glucometers Industry is based on end-users which includes veterinary hospitals, veterinary clinics, and home care settings.

Veterinary Glucometer Market is Boosted by Rising Pet Obesity Rates

Obesity is the main risk factor for developing diabetes. The main element influencing the adoption of veterinary glucometers is thought to be the rise in the number of obese dogs. Approximately 35% of pets, according to statistics from the American Veterinary Medical Association, are obese or overweight. Diabetes and liver disease are two conditions that can develop in overweight animals. If untreated, these disorders could be lethal. Therefore, during the projection period, key players are likely to witness a considerable increase in sales of veterinary glucometers due to the rising incidence of obese pet populations that are at a greater risk of getting diabetes.

Additionally, increased awareness of animal health presents a profitable opportunity for the manufacturers in the Global Veterinary Glucometers Industry. In addition, factors like an increase in the prevalence of diabetes in animals and a rise in the demand for livestock products also contribute to the veterinary glucometers market growth. However, the veterinary glucometers market growth is constrained by the absence of veterinary infrastructure facilities in poor countries.

Pet Glucose Monitors are devices used to measure the blood glucose levels of animals. These devices work in a similar way to human glucometers, using a small amount of blood to determine the glucose concentration in the blood.

Regional Analysis

What is the North America Growth Outlook for the Veterinary Glucometer Market?

North America is expected to lead the market with better healthcare facilities and growing advancing technology in the region. North American market holds a significant share of the veterinary glucometers market with 42% of the global market share. The rising demand for veterinary glucometers is mainly rising in the North American region due to the changing lifestyle of pets and animals, especially the native lifestyle being the biggest problem.

How is Europe Performing in the Veterinary Glucometer Market?

With a global market share of 33%, the European veterinary glucometers market is growing at a steady CAGR for veterinary glucometers. The second largest market is the Europe market followed by the Asia Pacific due to increasing awareness for veterinary diseases. The veterinary glucometers market in this region is anticipated to be one of the fastest growing markets due to a large number of animal populations and rising diseases amongst animals due to inactive lifestyles and poor management.

Recent mergers and product launches

Pro zinc (protamine zinc recombinant human insulin) was introduced by Boehringer Ingelheim International GmbH in August 2020 as a daily single-dose medication for dogs with diabetes.
In August 2019, Zoetis said that partner firms Merck Animal Health and Purina continue to support its Diabetes Pet Care Alliance initiative.
Nova Biomedical introduced the Ketone/Glucose Meter known as Nova Vet under its Nova biomedical section that measures blood beta-hydroxybutyrate (BHB) and gives the results in just 10 seconds. These fuel the sales of veterinary glucometers.
TaiDoc Technology Corporation has added new modern vet glucose monitoring machines that have a reaction time of 5 seconds with a memory of 400 sets. These fuel the sales of veterinary glucometers.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/5367

Veterinary Glucometer Market Key players

Nova Biomedical
TaiDoc Technology Corporation
BioNote Inc
Woodley Equipment Company Ltd
i-SENS. Inc.
MED TRUST
UltiMed, Inc.
Biotest Medical Corp

Veterinary Glucometer Market Key segments

By Animal Type:

Dogs
Cats

By End User:

Veterinary Hospitals
Veterinary Clinics
Homecare Settings

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

SPECT Scanning Services Market Poised for Explosive Growth: To Reach US$4.43 Billion by 2032, at a CAGR of 7.8% | FMI

The SPECT Scanning Services Market is on track for a remarkable upswing, fueled by advancements in radiopharmaceuticals and the growing need for non-invasive diagnostic imaging. A recent analysis projects a stellar Compound Annual Growth Rate (CAGR) of 7.8% from 2022 to 2032. This translates to a projected market value of a staggering US$4.43 billion by 2032, reflecting a significant leap from the US$1.95 billion valuation in 2022.

Several things contribute to this remarkable development trajectory, chief among them being the groundbreaking work in radiopharmaceuticals. SPECT scanning technology has seen new uses as a consequence of researchers’ and developers’ unwavering drive to develop state-of-the-art diagnostic solutions. As a result, the sector is being adopted by more medical specialties—cardiology, cancer, neurology, and so on—than ever before.

The global healthcare landscape is witnessing a surge in the prevalence of various health challenges, particularly an alarming increase in cancer cases, coupled with a rising incidence of brain diseases, heart difficulties, and bone disorders. In response to this critical demand for advanced diagnostic tools, SPECT scanning services are emerging as a crucial component of modern medical diagnostics.

Request a Sample of this Report By Using Your Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4122

The SPECT scanners consist of radioactive substances and a high-resolution camera to form 3D pictures. These devices are safe to use. The procedure involving the SPECT scanner is simple. A radioactive tracer is injected into the blood, which produces gamma rays. The camera captures the image, and this image is presented on the computer. The affected area will appear dark in color. Less tracker would mean the cell in the particular area is dead.

Top Drivers Influencing the SPECT Scanning Services Market
Increasing Investment in Research and Development:

With increasing cases of certain health complications like cancer, brain disorders, heart problems, and bone disorders, the medical community is investing heavily in research and development.

More and more usage of SPECT scanners is expected to analyze the condition of certain body parts during R&D. This might increase the demand for SPECT scanning services.

Wide Range of Applications:

One of the biggest advantages of using SPECT scanners is the wide range of applications they provide. The application further increases if they are used along with MRI and CT scans for better imaging quality and high-resolution images.

Accuracy:

The SPECT scanners are known to work with a high level of accuracy. The SPEC scanners operate based on nuclear medicine imaging techniques. The ability of nuclear imaging techniques to accurately detect molecular activity in the body and diagnose diseases at their earliest stages is expected to increase the demand for SPECT scanning services. Opportunities Ahead for the Global SPECT Scanning Services Industry

Opportunities:

Data Integrating Imaging Systems:

By using data-integrated imaging systems, it is possible to process and reconstruct images, identify medical conditions through computer-assisted recognition, create 3D images, and employ quality control measures. Data integration makes it easier for doctors to compare scans and track the disease’s progression. This is expected to change the outlook of Global SPECT Scanning Services Industry

SPECT Scanning Services Market Competitive Landscapes:

What are the Major Players in the SPECT Scanning Services Market?

The global demand for SPECT scanning services is highly fragmented and competitive due to the presence of numerous regional and local companies. Major players use a variety of marketing strategies, including mergers and acquisitions, developments, alliances, and partnerships.

Increasing a company’s consumer market share also entails developing new products. As a result of these advancements, the effectiveness of SPECT scanning services has increased.

Some of the key players are Gamma Medica Inc., GE Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, Mediso Medical Imaging Systems Ltd., Digirad Corporation, Positron Corporation, DDD Diagnostics, Cubresa Inc., and others.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-4122

SPECT Scanning Services Market Key segments

By Design:

Encapsulated
Linear resonant actuators
PCB mounted
brushless coin
Brushed coin
Eccentric rotating mass

By Product Type:

Eccentric rotating mass vibration motor (ERM)
DC motor

By Application:

Medical
Commercial
Cruise shipbuilding and ship repair

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Air Fluidized Therapy Beds Market Expected to Grow Strong at 5.7% CAGR and Reach US$1.1 Billion by 2033 | FMI Analysis

The Air Fluidized Therapy Beds Market is poised for significant growth, fueled by the increasing need for advanced wound care solutions. A recent study by Future Market Insights (FMI) forecasts a compelling Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2033. This translates to a projected market value of approximately US$1.135 million by 2033, reflecting a substantial increase from the current market valuation of US$700 million.

Air fluidized therapy beds, also known as low-air-loss mattresses or alternating pressure mattresses, are designed to provide optimal support and pressure relief to patients, especially those who are immobile or bedridden for extended periods. The growing demand for these beds can be attributed to several factors, including the increasing prevalence of chronic conditions such as obesity, diabetes, and cardiovascular diseases, which require prolonged bed rest. Additionally, the rising geriatric population and the growing awareness about the benefits of air-fluidized therapy beds are also expected to drive the market’s growth.

The demand for these beds is on the rise worldwide, driven by technological innovations and advancements in medical treatments. Hospitals are increasingly adopting air-fluidized therapy beds to cater to the evolving needs of patients and provide cutting-edge healthcare solutions. The beds are not only crucial for burn patients but are also gaining prominence in addressing skin-related conditions.

Request a Sample of this Report By Using Your work email to get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5035

Air Fluidized Therapy Beds Market Key Takeaways

By 2033, the air fluidized therapy bed market in the United Kingdom is likely to expand, with a CAGR of 4.7%.
In 2022, the United States developed the air fluidized therapy bed business with a share of 36%.
The air fluidized therapy bed market grew considerably to US$ 635.3 million in 2022.
The air-fluidized therapy bed sector expanded at a CAGR of 4.1% from 2018 to 2022.
By 2033, China’s air-fluidized therapy bed market is projected to develop with a CAGR of 7%.
By 2033, India’s air-fluidized therapy bed industry is projected to expand with a CAGR of 5.7%.
Japan’s air fluidized therapy bed industry grew significantly, with a 3.8% share in 2022.
Australia’s air-fluidized therapy bed is likely to expand with a CAGR of 5.1% by 2033.
Germany’s air fluidized therapy bed business grew, with a share of 8.2% in 2022.
In 2022, based on the indication, pressure ulcers dominated the market, with a share of 57.3%.
In 2022, the hospitals segment dominated the market, with a share of 62.1%, based on end-user

Air Fluidized Therapy Beds Market Competitors Winning Strategies

Local and regional manufacturers serve certain geographic areas through regionalized customer assistance, affordable solutions, and in-depth knowledge of regional healthcare practices and laws.

Gaining the faith and confidence of healthcare institutions, experts, and end users is imperative for market players, and compliance with regulatory requirements and certifications is key to this.

To guarantee the best possible use of air-fluidized treatment beds, businesses offer outstanding customer service, prompt maintenance assistance, and thorough training programs for healthcare professionals.

Baxter became the top Medtech company in the world in December 2021 when it acquired Hill-Rom for US$ 15 billion. As a result, Baxter improved its technology, giving patients greater treatment in hospitals and at home. Moreover, Baxter anticipates a significant ROIC from this purchase.

Air Fluidized Therapy Beds Market Key players

Hill-Rom,
Dolphin System
AURORA MFG,
American Medical Equipment
Blue Chip Medical
Akthel Healthcare BV
ArjoHuntleigh

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/5035

Air Fluidized Therapy Beds Market Key Segments

By Indication:

Pressure Ulcers
Burns
Other Indications

By End User:

Hospitals
Ambulatory Surgical Centers
Other End Users

By Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Staphylococcus Aureus Testing Market is expected to grow steadily at a 5.3% annual rate and reach US$6.9 Billion by 2033 | FMI

The fight against staph infections is getting a boost from a growing market for diagnostic testing. According to a recent analysis, the Staphylococcus Aureus Testing Market is poised for steady growth, reaching an estimated US$6.9 billion by 2033. This translates to a Compound Annual Growth Rate (CAGR) of 5.3% from 2023 to 2033. This significant expansion reflects the increasing need for accurate diagnosis and effective treatment of infections caused by this common but potentially dangerous bacteria.

Request a Sample of this Report By Using Your work email to get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5284

Several Factors Driving the Global Market Significantly to Acquire Huge Revenue. These are as follows:

Increasing Prevalence of Staphylococcus Aureus Infections: The rising bacterial diseases such as Staphylococcus aureus include bloodstream infections, pneumonia, skin infections, and surgical site infections. The growing number of these infections worldwide is increasing the adoption of staphylococcus aureus testing.
Rising Awareness and Concerns: Healthcare professionals and patients have growing awareness towards Staphylococcus aureus strains, including MRSA (Methicillin-resistant Staphylococcus Aureus). It helps to manage and identify antibiotic-resistant strains.
Increasing Healthcare-Associated Infections: The rising incidence of Healthcare-Associated Infections and increasing the demand for staphylococcus aureus testing for effective testing. It helps to prevent and control these diseases speedily in healthcare settings.
Advanced Diagnostic Technologies: The growing advanced technologies, such as nucleic acid amplification tests and immunoassays, are increasing the demand for staphylococcus aureus testing for accurate and reliable testing. Healthcare professionals who focus on treating patients are driving the global market.
Increasing Demand for Point-of-Care Testing: The growing patient treatment, rapid diagnosis, and immediate treatment decisions are increasing the adoption of point-of-care testing. It is widely adopted in various healthcare settings such as clinics, hospitals, emergency departments, and ambulatory care.
Growing Investments in Research and Development Activities: The huge rising investment in research and development activities to introduce new testing tactics driving the global market growth.

Staphylococcus Aureus Testing Market Key Takeaways:

The Staphylococcus aureus testing market is estimated to capture a valuation of US$ 6.9 billion with a CAGR of 5.3% by 2033.
In the historical period, the market secured a valuation of US$ 3.9 billion with a CAGR of 6.7% in 2022
North America is significantly driving the global market by capturing a share of 48.7% in the global market by 2033.
Europe is estimated to register a share of 33.4% in the global market during the forecast period.
The hospital sector is securing a maximum global market share by 2033.

How Key Players Are Adopting Strategic Innovations in the Staphylococcus Aureus Testing Market?

The market is highly competitive by the prominent players that heavily invest in research and development activities. These players play a key role in developing improved, advanced, and innovative products globally. They focus on consumers’ requirements and offer them high-quality, customized products.

These players are adopting various marketing strategies to drive the global market to another level. These marketing tactics are mergers, acquisitions, collaborations, partnerships, agreements, and product launches. Key players promote their brands on several platforms, such as online retailers, seminars, exhibitions, trade shows, and online marketing.

Recent Developments in the Staphylococcus Aureus Testing Market are:

Roche Diagnostics announced its newly launched product molecular diagnostic solution for Staphylococcus aureus testing. The company offers customized molecular diagnostic solutions with its specialized team to enhance its business portfolio.

Staphylococcus Aureus Testing Market Key Companies Profiled

Abbott Laboratories Inc
Siemens Healthcare GmbH
Bio Rad Laboratories Inc
Thermo Fisher Scientific Inc
Roche Diagnostics (H. Hoffman-La Roche Ltd.)
STD Rapid Test Kits

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/5284

Staphylococcus Aureus Testing Market by Category

By Test Type:

Coagulase Test
Ancillary Tests
Agar-Based Tests
Nucleic Acid Amplification Tests

By Application:

Pharmaceutical
Clinical
Food Testing
Other

By End User:

Hospitals
Diagnostic Clinics
Food Testing laboratories
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Hemostasis Products Market is expected to grow steadily at a 5.3% CAGR and reach US$2.65 Billion by 2033 | FMI

The Hemostasis Products Market is poised for robust growth, driven by the increasing need for effective bleeding management solutions. A recent analysis by Future Market Insights (FMI) forecasts a consistent Compound Annual Growth Rate (CAGR) of 5.3% from 2023 to 2033. This translates to a projected market valuation of a staggering US$2.65 billion by 2033, reflecting a significant rise from the estimated US$1.58 billion in 2023.

Prominent technical developments, robust economies, and an abundance of patients suffering from a range of blood diseases are the main reasons that will propel the hemostasis product market shortly. Cardiovascular disease, stroke, cancer, and trauma are the main reasons for surgery. Additionally, any surgical treatment has the risk of serious complications and uncontrollable heavy bleeding, which drives up demand for hemostasis supplies.

The rapidly growing medical tourism sector coupled with the high investment made by governments of various countries towards the growth of the healthcare sector will provide lucrative opportunities for the growth of the market. The high expenses related to hemostasis products stringent regulatory policies and the use of off-label products are projected to restrain the market’s growth over the forecast period.

Request a Sample of this Report By Using Your Work Email to Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15386

The topical hemostasis product segment is likely to offer remunerative opportunities for the Global Hemostasis Products Industry. Several emerging economies are making significant developments in their technological sector, thereby, providing lucrative opportunities to players in the market.

Hemostasis Products Market Key Takeaways:

The Global Hemostasis Products Industry is estimated at USD 1,501 Million in 2021
By product, the topical hemostat segment accounts for a market share of 68.5% in 2021
By application, the myocardial infarction segment accounts for the highest market share of 19.5% during the forecasting period.
Market in the U.S. to procure a market share of 29.5% during the assessment period.

“The increasing number of trauma and surgical cases, technological advancements in the fields of hemostasis products, and an increase in the prevalence of blood disorders are expected to fuel the demand for Global Hemostasis Products Industry over the forecast period” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Hemostasis Products Market Competitive Landscape

Medtronic
Johnson & Johnson
Baxter International
Pfizer Inc.
Becton Dickinson and Company (BD)
B. Braun Melsungen AG
Tricol Biomedical
Hemostasis LL
Teleflex Incorporated
CuraMedical BV

Recent updates from the industry are:

In July 2021- Baxter International Inc. announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClotPolysaccharide Hemostatic System from CryoLife, Inc. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room. PerClot has a global commercial presence with sales in more than 35 countries worldwide.
Hemostasis is committed to producing high-quality medical devices that are safe and effective for their intended use. Hemostasis introduced. BoneSeal bone hemostat is a new-generation, absorbable solution providing immediate and long-term hemostasis without immediately dissolving. BoneSeal hemostat works quickly and delivers better results for you and your patients.

To Purchase this Report Visit
https://www.futuremarketinsights.com/checkout/15386

Key Segments Covered in the Global Hemostasis Products Industry Analysis

Hemostasis Products Market by Product:

Topical Hemostasis Products
- Gelatin
- Polysaccharides
- Oxidized Regenerated Cellulose
- Collagen
Infusible Hemostasis Products
- Platelet Concentrate from Donor Blood
- Fresh Frozen Plasma (FFP)
- Factor VIII
- Prothrombin
Advanced Hemostasis Products
- Flowable
- Thrombin
- Synthetic Sealants
- Fibrin

Hemostasis Products Market by Application:

Hemostasis Products for Trauma
Hemostasis Products for Surgery
Hemostasis Products for Hemophilia
Hemostasis Products for Myocardial Infarction
Hemostasis Products for Others

Hemostasis Products Market by End Use:

Hemostasis Products in Hospitals
Hemostasis Products in Ambulatory Surgical Centers
Hemostasis Products in Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: